IL6 and cancer: Ginsenoside Rb1 can reduce the release of TNF-α and IL-6 in a rat model of bone pain caused by cancer [15] and it can inhibit the expression of TNF-α and IL-6 induced by intestinal ischemia/reperfusion injury in rats [16].